TSVT
Income statement / Annual
Last year (2023), 2seventy bio, Inc.'s total revenue was $100.39 M,
an increase of 9.72% from the previous year.
In 2023, 2seventy bio, Inc.'s net income was -$217.57 M.
See 2seventy bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$100.39 M
|
$91.50 M
|
$54.52 M
|
$248.12 M
|
$44.30 M
|
$54.58 M
|
| Cost of Revenue |
$2.10 M |
$26.22 M |
$12.59 M |
$5.40 M |
$2.98 M |
$885,000.00 |
| Gross Profit |
$98.29 M |
$65.28 M |
$41.93 M |
$242.73 M |
$41.32 M |
$53.69 M |
| Gross Profit Ratio |
0.98 |
0.71 |
0.77 |
0.98 |
0.93 |
0.98 |
| Research and Development
Expenses |
$230.76 M
|
$248.74 M
|
$261.94 M
|
$296.47 M
|
$297.65 M
|
$200.49 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$69.41 M
|
$79.45 M
|
$93.51 M
|
$90.90 M
|
$81.65 M
|
$53.63 M
|
| Other Expenses |
$20.91 M |
$6.06 M |
$21.65 M |
$18.06 M |
$20.13 M |
$19.16 M |
| Operating Expenses |
$289.89 M |
$328.19 M |
$355.44 M |
$387.36 M |
$379.29 M |
$254.12 M |
| Cost And Expenses |
$317.09 M |
$354.40 M |
$368.03 M |
$392.76 M |
$382.27 M |
$255.01 M |
| Interest Income |
$12.41 M |
$2.93 M |
$88,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$15.49 M |
| Depreciation &
Amortization |
$10.29 M
|
$11.53 M
|
$16.40 M
|
$13.19 M
|
$12.59 M
|
$13.35 M
|
| EBITDA |
-$206.42 M
|
-$251.38 M
|
-$297.16 M
|
-$131.45 M
|
-$329.19 M
|
-$187.08 M
|
| EBITDA Ratio |
-2.06 |
-2.74 |
-5.74 |
-0.46 |
-7.28 |
-3.08 |
| Operating Income Ratio
|
-2.16
|
-2.87
|
-5.75
|
-0.58
|
-7.63
|
-3.73
|
| Total Other
Income/Expenses Net |
-$867,000.00
|
$8.76 M
|
$21.30 M
|
$24.52 M
|
$17.38 M
|
$3.68 M
|
| Income Before Tax |
-$217.57 M |
-$254.15 M |
-$292.21 M |
-$120.11 M |
-$320.59 M |
-$199.75 M |
| Income Before Tax Ratio
|
-2.17
|
-2.78
|
-5.36
|
-0.48
|
-7.24
|
-3.66
|
| Income Tax Expense |
$0.00 |
-$8,987.00 |
-$16.00 M |
$18.06 M |
$2.75 M |
$19.16 M |
| Net Income |
-$217.57 M |
-$254.14 M |
-$276.21 M |
-$138.17 M |
-$323.34 M |
-$199.75 M |
| Net Income Ratio |
-2.17 |
-2.78 |
-5.07 |
-0.56 |
-7.3 |
-3.66 |
| EPS |
-4.42 |
-7.13 |
-11.71 |
-5.93 |
-13.88 |
-8.58 |
| EPS Diluted |
-4.42 |
-7.13 |
-11.71 |
-5.93 |
-13.88 |
-8.58 |
| Weighted Average Shares
Out |
$49.28 M
|
$35.64 M
|
$23.59 M
|
$23.29 M
|
$23.29 M
|
$23.29 M
|
| Weighted Average Shares
Out Diluted |
$49.28 M
|
$35.64 M
|
$23.59 M
|
$23.29 M
|
$23.29 M
|
$23.29 M
|
| Link |
|
|
|
|
|
|
